Genetic alterations with potential impact on PD-(L)1 targeted treatment in various cancer entities – Biobank research project of the INFINITY registry 5. Juni 2023 Hillebrand LE, Vannier C, Jermann PM , Matter M, Läubli H, Grebhardt S, Wright PR, Woerner SM, Kansenda B, Marschner N, Potthoff K. Download The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice. Martens UM, Schröder J, Bengsch F, Sellmann L, Busies S, Frank-Gleich S, Zaiss M, Decker T, Schneeweiss A, Schuler M, Grebhardt S, Zacharias S, Marschner… Weiterlesen Tucatinib in patients with locally advanced or metastatic HER2-positive breast cancer who received at least two prior anti-HER2 treatment regimens: Study design of the non-interventional study TRACE in Germany and Austria N. Harbeck , R. Bartsch , V. Müller , M. Balic , D. Egle , E. Schumacher-Wulf , M. Angerer , A. Nusch , C. Weiterlesen